Signature Equity Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Signature Equity Partners's IDXX Position: Q2 2026 in Review
Signature Equity Partners reduced its Idexx Laboratories (IDXX) stake by 98% in Q2 2026, selling an estimated $132K and leaving 5 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.
Signature Equity Partners first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $135K in Q1 2026. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Signature Equity Partners held 5 shares of Idexx Laboratories worth $2.63K as of Q2 2026.
- Signature Equity Partners sold 236 Idexx Laboratories shares in Q2 2026, an estimated $132K.
- Idexx Laboratories made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1121 holding.
- Signature Equity Partners first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
- Signature Equity Partners's Idexx Laboratories position peaked at $135K in Q1 2026.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.